Karachi May 10 2024: Pfizer Pakistan sold its manufacturing facility along with rights of some pharmaceutical products to Lucky Group Company.
The Board of Directors of Lucky Core Industries Limited (the ‘Company’) have approved the purchase of a manufacturing facility owned by Pfizer Pakistan Limited located at B2 SITE Karachi, along with the acquisition of certain pharmaceutical products, and the acquisition of trademarks associated with the said pharmaceutical products (either through an outright assignment of the trademarks or a perpetual Iicense to use the relevant trademarks) from relevant Pfizer group entities.
The Board of Directors of the Company have further authorized the finalization and execution (as necessary) of the definitive transaction documents/agreements including the Asset Purchase Agreements, Trademark License Agreement and ali ancillary documents fonning par! of the transaction with Pfizer Pakistan Limited andlor its group entities (as applicable). The completion of the transaction will be subject to receipt of necessary approvals and completion of formalities.
